Noom vs Found: Behavior-First and Clinical-First Weight Care

This comparison is published through the PlexusDx Education Hub, our resource for GLP-1 therapies, weight-care models, and the metabolic genetics behind them. Open the full Peptides & GLP-1 hub.

Independent editorial comparison. PlexusDx has no commercial relationship with Noom or Found and receives no affiliate payment for mentioning either program.

Comparing Noom with Found means comparing two philosophies more than two drugstores. Noom made its name as a behavior-change and psychology app, later bolting on a medication route; Found starts from the prescription. This piece contrasts those starting points, the pharmacology they ultimately share, what each monthly fee buys, and the genetics sitting under both. As of April 2026.

Different starting points: an app versus a clinic

Noom and Found diverge at the root. Noom built its identity as a psychology-driven behavior-change app, later adding a medication route; Found started from clinical prescription. That heritage colors everything downstream — one leads with habit coaching and food logging, the other with a provider and a script. Both can end up delivering a GLP-1, but they arrive there by different roads.

Noom: behavior change with a medication add-on

Noom, Inc. operates as an app-based subscription with a medication add-on. When medication is part of the plan, the structure resembles other telehealth models: virtual clinical evaluation, provider-issued prescriptions, and either FDA-approved brand dispensing or compounded semaglutide and tirzepatide through licensed 503A pathways. Current program details are on Noom's official website.

Found: prescription-led subscription

Found leads with the clinical side. After intake and eligibility review, a licensed provider issues a prescription routed to a retail or compounding pharmacy, with follow-up supporting titration. The behavior-support layer exists, but the organizing principle is the medication track rather than an app-first curriculum. See Found's official website for specifics.

The pharmacology both models share

Whatever wrapper surrounds it, the drug is the drug. GLP-1 receptor agonists and the dual agonist tirzepatide act on appetite regulation, satiety, and gastric emptying, and the supporting evidence — STEP (NEJM 2021), SURMOUNT (NEJM 2022), SURMOUNT-OSA (NEJM 2024) — belongs to the compounds. Neither an app nor a subscription changes that underlying mechanism.

What your monthly fee is buying

With Noom, part of the fee funds coaching and the app experience; with Found, it funds clinical service and fulfillment. Across GLP-1 telehealth as of April 2026, monthly totals typically run from roughly $200 to $700+ depending on medication, tier, and dispensing route. Confirm current numbers on each brand's own pricing page before you commit.

The genetic variable no subscription reads

Here is the layer none of these telehealth workflows examine: the inherited biology that sets the stage before any GLP-1 molecule arrives. Variants in FTO, MC4R (central to satiety signaling), and GLP1R shape the appetite and energy-balance biology that behavior coaching and medication both act on. These are pathway-level markers. They do not predict how you will respond to any particular drug, but they describe the metabolic terrain a prescriber is writing into. The PlexusDx Precision Peptide Genetic Test reads 14 pathways, 49 peptides, 150+ genetic insights across that terrain, mapping appetite regulation, satiety, and energy-balance biology so a conversation with your own clinician starts from data rather than guesswork. It is not a pharmacogenomic test and never forecasts a medication's effect.

PlexusDx provides semaglutide and tirzepatide through its Weight Management Protocols, available as Semaglutide Injection, Semaglutide Oral, Tirzepatide Injection, and Tirzepatide Oral. Rather than lead with an app or a coach, it leads with your genetic profile and builds the protocol from there.

Not affiliated: PlexusDx has no affiliation and no commercial relationship with Noom or the other programs discussed in this review.

Related reading on PlexusDx: GLP 1 Drugs, GLP 1 Hormone, What Is GLP 1, GLP 1 What Is.

For education only. PlexusDx has no affiliation with Noom or Found and no commercial relationship with either. PlexusDx offers semaglutide and tirzepatide under its own Weight Management Protocols, and this piece compares telehealth models. The Precision Peptide Genetic Test measures gene–pathway influence, not drug response. Consult a qualified clinician before starting a peptide protocol.

Prefer to start with data? See the PlexusDx Weight Management Protocols, or take the Precision Peptide Genetic Test to understand your appetite and energy-balance genetics first.

Frequently Asked Questions

Is Noom's coaching worth it compared to Found?

That depends on what you want from a program. Noom emphasizes behavior change and coaching with an optional medication route; Found leads with the clinical prescription. If structured habit support motivates you, Noom's model may appeal; if you prioritize the medication track, Found's focus may fit. Neither approach changes the underlying pharmacology.

Do you need medication with Noom?

Not necessarily. Noom began as a behavior-change app, and medication is an add-on rather than the core. Found, by contrast, is organized around the prescription. If you are specifically seeking a GLP-1, confirm that a given plan includes the medication route and how it is dispensed before enrolling.

Can you use Noom and Found together?

Some people combine behavior tools with a medical program, but you should not stack two prescribing services or duplicate medications. Any medication decision belongs with a licensed clinician who sees your full picture. Coordinate care through one prescriber to avoid conflicting instructions or unsafe overlap.

How does genetic insight relate to behavior-based programs?

Genetics sits beneath both coaching and medication. Variants in FTO, MC4R, and GLP1R shape appetite and energy balance regardless of program style. The Precision Peptide Genetic Test maps that baseline context — it does not predict response to any drug or coaching plan, but it informs the conversation with your provider.

This article is part of the PlexusDx Education Hub. Browse all Peptides & GLP-1 education.